We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
(+60%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
34.53%
Top 10 Holdings %
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.52M |
| 2 |
Keurig Dr Pepper
KDP
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.19M |
| 4 |
AET
Aetna Inc
AET
|
+$2.17M |
| 5 |
PNC Financial Services
PNC
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$1.39M |
| 2 |
Eaton
ETN
|
+$1.38M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$1.35M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$1.32M |
| 5 |
DaVita
DVA
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.9% |
| 2 | Consumer Discretionary | 14.51% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 13.03% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
501
Novo Nordisk
NVO
$228B
| $7K | ﹤0.01% |
262
-2,200
| -89% | -$58.9K |
|
502
V2X
VVX
$2.7B
| $7K | ﹤0.01% |
311
| – | – |
|
503
Acadia Healthcare
ACHC
$2.52B
| $6K | ﹤0.01% |
100
-2,400
| -96% | -$137K |
|
504
Capri Holdings
CPRI
$1.82B
| $5K | ﹤0.01% |
+95
| New | +$4.69K |
|
|
CDK
505
DELISTED
CDK Global, Inc.
CDK
| $5K | ﹤0.01% |
+100
| New | +$4.45K |
|
506
Dana Inc
DAN
$2.88B
| $4K | ﹤0.01% |
+254
| New | +$3.17K |
|
|
THS
507
DELISTED
Treehouse Foods
THS
| $3K | ﹤0.01% |
+36
| New | +$2.88K |
|
508
West Pharmaceutical
WST
$23.7B
| $3K | ﹤0.01% |
+43
| New | +$2.59K |
|
509
Baidu
BIDU
$35.7B
| $2K | ﹤0.01% |
+11
| New | +$1.87K |
|
510
Southwest Airlines
LUV
$21.7B
| $2K | ﹤0.01% |
34
-3,800
| -99% | -$155K |
|
|
EGRX
511
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2K | ﹤0.01% |
+40
| New | +$2.54K |
|
|
FRC
512
DELISTED
First Republic Bank
FRC
| $2K | ﹤0.01% |
31
-4,100
| -99% | -$263K |
|
|
MXIM
513
DELISTED
Maxim Integrated Products
MXIM
| $2K | ﹤0.01% |
47
-6,700
| -99% | -$225K |
|
514
Loews
L
$24.5B
| $1K | ﹤0.01% |
35
-8,800
| -100% | -$324K |
|
515
Steel Dynamics
STLD
$36.4B
| $1K | ﹤0.01% |
65
-1,800
| -97% | -$33.9K |
|
516
UGI
UGI
$7.87B
| $1K | ﹤0.01% |
33
-3,200
| -99% | -$116K |
|
|
ABB
517
DELISTED
ABB Ltd
ABB
| $1K | ﹤0.01% |
+36
| New | +$636 |
|
|
BMS
518
DELISTED
Bemis
BMS
| $1K | ﹤0.01% |
22
-3,200
| -99% | -$154K |
|
519
Alcoa
AA
$11.3B
| $0 | ﹤0.01% |
+8
| New | +$163 |
|
520
Advance Auto Parts
AAP
$3.53B
| – | – |
-997
| Closed | -$150K |
|
521
Asbury Automotive
ABG
$4.62B
| – | – |
-1,400
| Closed | -$94K |
|
522
Abbott
ABT
$188B
| – | – |
-15,000
| Closed | -$674K |
|
523
Acadia Pharmaceuticals
ACAD
$4.51B
| – | – |
-14,400
| Closed | -$513K |
|
524
Arch Capital
ACGL
$36.5B
| – | – |
-6,000
| Closed | -$140K |
|
525
Archer Daniels Midland
ADM
$38.7B
| – | – |
-6,196
| Closed | -$227K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.
- Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
- Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
- Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
- Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
- Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
- Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.
Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.